Cite
HARVARD Citation
Landewé, R. et al. (n.d.). OP0334 Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA). Annals of the rheumatic diseases. p. 213. [Online].